Gila Therapeutics Is A Boston Based Clinical Stage Biotech Company Exploiting A Novelhighly Targeted Neural Signaling System For The Treatment Of Obesitytype 2 Diabetes And Associated Metabolic Disordersour Innovative Topical Lingual Neural Signaling Platform Facilitates The Direct Activation Of Specific Brain Regions Responsible For Metabolic Regulation Through The Delivery Of Natural Peptide Hormones Without Expectation Of Side Effectsour Scientific Advisory Team Is Renowned Globally For Their Unrivaled Experience And Pioneering Contributions To The Fields Of Endocrinologyneuroscienceand Metabolic Nephrologyreach Out To Learn More About Us
